U
ABBV icon

UBS’s AbbVie ABBV Stock Holding History

UBS’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$202M Buy
3,492,813
+101,378
+3% +$5.63M 0.15% 151
2014
Q2 		$191M Sell
3,391,435
-425,121
-11% -$22.3M 0.15% 158
2014
Q1 		$196M Sell
3,816,556
-508,633
-12% -$25.7M 0.17% 129
2013
Q4 		$228M Sell
4,325,189
-128,960
-3% -$6.34M 0.21% 98
2013
Q3 		$199M Buy
4,454,149
+799,816
+22% +$35.5M 0.2% 103
2013
Q2 		$151M Buy
+3,654,333
New +$160M 0.18% 124

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

UBS's ABBV Position: Q3 2014 in Review

UBS increased its AbbVie (ABBV) stake by 3% in Q3 2014, buying an estimated $5.63M and bringing the position to 3,492,813 shares worth $202M. The position accounts for 0.15% of the portfolio, ranked #151.

UBS first reported a position in ABBV in Q2 2013 and has held it in 6 quarters since. The position peaked at $228M in Q4 2013. 1,502 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • UBS held 3,492,813 shares of AbbVie worth $202M as of Q3 2014.
  • UBS bought 101,378 AbbVie shares in Q3 2014, an estimated $5.63M.
  • AbbVie made up 0.15% of UBS's portfolio in Q3 2014, its #151 holding.
  • UBS first reported a position in AbbVie in Q2 2013 and has held it in 6 quarters since.
  • UBS's AbbVie position peaked at $228M in Q4 2013.
  • 1,502 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.